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ABSTRACT: Novel water-soluble decacationically armed C60 and C70
decaiodide monoadducts, C60- and C70[>M(C3N6
+C3)2], were synthesized,
characterized, and applied as photosensitizers and potential nano-PDT
agents against pathogenic bacteria and cancer cells. A high number of
cationic charges per fullerene cage and H-bonding moieties were designed
for rapid binding to the anionic residues displayed on the outer parts of
bacterial cell walls. In the presence of a high number of electron-donating
iodide anions as parts of quaternary ammonium salts in the arm region, we
found that C70[>M(C3N6
+C3)2] produced more HO
• than C60[>M-
(C3N6
+C3)2], in addition to
1O2. This ﬁnding oﬀers an explanation of the
preferential killing of Gram-positive and Gram-negative bacteria by C60[>M(C3N6
+C3)2] and C70[>M(C3N6
+C3)2], respectively.
The hypothesis is that 1O2 can diﬀuse more easily into porous cell walls of Gram-positive bacteria to reach sensitive sites, while
the less permeable Gram-negative bacterial cell wall needs the more reactive HO• to cause real damage.
■ INTRODUCTION
Photodynamic therapy (PDT)1−4 employs the combination of
nontoxic photosensitizers (PS) with harmless visible to near-IR
light to generate highly reactive oxygen species (ROS) such as
singlet oxygen (1O2), superoxide radicals (O2
−•), or hydroxyl
radicals (HO•) that kill disease-causing cells by a nonspeciﬁc
attack.5,6 Increasing prevalence of multiantibiotic drug resist-
ance in multiple classes of pathogens7,8 contributes to the
diﬃculty in treating the related infectious diseases. Because
these pathogens may be deﬁcient in defenses against ROS,
especially singlet oxygen and hydroxyl radicals that display a
nonspeciﬁc high reactivity toward certain critical chemical
moieties of the cell, the PDT approach may serve as a
promising alternative treatment method for infections and
cancer. The nonspeciﬁcity nature of PDT also allows its use
against a wide range of bacteria, viruses, yeasts, and protozoa by
killing these pathogenic agents in the infection.
The reaction mechanism of PDT involves an initial
photoexcitation of PS to the singlet excited state upon exposure
to a light source, followed by intersystem crossing processes
resulting in the formation of a long-lived triplet excited state of
PS that can transfer photoenergy to triplet molecular oxygen in
the biological system. Accordingly, an eﬀective organic PS
should be capable of exhibiting (1) a strong and sharp optical
absorption band at the PDT wavelength for a high yield of
photoexcitation, (2) a high yield of molecular triplet excited
state generation, and (3) eﬀective molecular interactions with
the target cell surface to produce ROS in a short distance
without undue damage to the surrounding host tissue.
Fullerenes are particularly photostable and manifest little
photobleaching compared to many other traditional tetrapyr-
role-backbone based PS found in porphyrins and chlorins.9
Rapid photobleaching characteristics of porphyrin-type PS
often disrupt its PDT eﬃcacy after a short period of light
illumination mainly because of photodegradation of the
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compound and subsequent alteration of its chromophore
structure, resulting in the loss of photosensitizing capability. By
contrast, a larger number of interlinked aromatic oleﬁnic bonds
available on the fullerene cage can tolerate a certain degree of
fullerenyl π-conjugation interruption, induced by the back-
attack of singlet oxygen or radical species on the oleﬁn bonds,
delaying the loss of their photophysical properties. This
chemical nature coupled with a relatively slower reaction rate
of C60 and C70 cages toward ROS than that of porphyrin-type
PS leads to a photostability that dramatically extends the length
of time they can respond to illumination. It will also allow many
more eﬀective catalytic PDT cycles to be carried out with a
single application of PS.
Our particular interest is in mediating broad-spectrum PDT
killing of pathogenic Gram-positive (e.g., Staphylococcus aureus)
and Gram-negative (e.g., Escherichia coli) bacterial targets.
Owing to speciﬁc diﬀerences in the physiology, cell wall, and
cytoplasmic membrane structures between Gram-positive and
Gram-negative bacteria,10−12 it is necessary to signiﬁcantly
revise the functional addends of each fullerene cage for eﬀective
targeting selectivity and drug delivery. By taking chemical
functional groups and structures of the cell wall into account to
maximize potential interaction forces of drugs at the cell
surface, the combination of H-bonding and a high number of
cationic charges in one molecular compound is beneﬁcial for
inducing strong binding. However, synthesis of fullerenyl
monoadducts bearing a well-deﬁned high number of cationic
charges remains challenging and has rarely been reported.
In this paper, we describe a rational linkage of water-soluble
quaternary alkylammonium multisalts and ester amide func-
tional groups into a well-deﬁned decacationic malonate
together with an eﬃcient synthetic method for its attachment
on either a C60 or C70 nanocage. The synthesis led to the
preparation of new amphiphilic [60]fullerene-based (1) or
[70]fullerene-based (2) nanophotosensitizers, respectively. In
these structures, arm moieties each bearing a high number of
cationic charges and an amide moiety, capable of inducing the
H-bonding in the vicinity of the fullerene cage, are designed for
cell targeting. Accordingly, they may allow us to study
speciﬁcally the feasibility as nano-PDT agents toward both
Gram-positive and Gram-negative bacterial species.2,13 The
approach also gives a systematic structure−function relation-
ship of fullerene monoadducts on the inﬂuence of their
biological activity, aiming to achieve the optimized photo-
dynamic activation and enhancement of the PDT eﬃciency.
■ RESULTS AND DISCUSSION
Surface binding interactions of fullerene derivatives with -D-Ala-
D-Ala residues of the bacteria cell wall may be increased by the
incorporation of polar moieties on C60/C70 capable of inducing
multiple H-bondings and static charge interactions with amino
acid functional residues. On the basis of this consideration, we
applied a malonate precursor arm, as that shown in the
structures of C60[>M(C3N6
+C3)2] 1 and C70[>M(C3N6
+C3)2]
2 (Scheme 1), to include two esters and two amide moieties for
a suﬃcient number of carbonyl and -NH groups in a short
length of ∼20 Ǻ for making eﬀective multibinding sites. More
importantly, the use of a well-deﬁned water-soluble pentaca-
tionic moiety N6
+C3 at each side of the arm may increase the
crucial select-targeting speciﬁcity on the bacterial cell wall.
Thus, N6
+C3 becomes a common synthon for the structural
modiﬁcation of PDT nanomedicines. It can be derived from the
quarternization of N,N′,N,N,N,N-hexapropylhexa(aminoethyl)-
amine precursor N6C3. Attachment of N6
+C3 to two ester
Scheme 1. Synthetic Pathway for the Preparation of Decacationic C60[>M(C3N6
+C3)2] 1 and C70[>M(C3N6
+C3)2] 2
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moieties of a malonate forms two extended bipolar
pentacationic side arms capable of forming strong static-charge
binding interactions to anionic carboxylate end-groups of the
terminal D-Ala-D-Ala dipeptide of the bacterial cell wall.
Synthetically, large solubility-incompatibility between water-
soluble pentacationic intermediate N6
+C3 side arms and highly
hydrophobic fullerene cage incurred much challenge and
diﬃculty in controlling the reaction homogeneity and overall
processes for the exclusive monoadduct formation, the
eﬃciency and yield, and the product puriﬁcation and
characterization. Following many attempts using diﬀerent
synthetic routes, we found that the best approach for the
preparation of decacationic bis(20-oxo-4,7,10,13,16-pentaprop-
yl-4,7,10,13,16,19-hexaazatricosan-23-yl)[60]fullerenyl malo-
nate methyl quaternary ammonium salt 1 and its C70 analogue
compound 2 is to begin with a simple well-deﬁned fullerene
monoadduct derivatives, such as di(tert-butyl)fullerenyl malo-
nates C60[>M(t-Bu)2] 3 and C70[>M(t-Bu)2] 4, respectively,
capable of undergoing the chemical conversion reaction with
N6
+C3-derived intermediates, as shown in Scheme 1. The
alternative approach to synthesize ﬁrst the water-soluble N6
+C3-
malonate-N6
+C3 intermediate arm followed by its attachment to
a fullerene cage resulted in much complication in the product
puriﬁcation and characterization, even though the same
compound was obtained. One potentially plausible synthetic
route of using the hydrophobic N6C3-malonate-N6C3 inter-
mediate arm was found to be problematic owing to its partial
charge-transfer complexation with the [70]fullerene cage.
The structural veriﬁcation of 4 was made by various
spectroscopic techniques, including 13C NMR spectrum
(Supporting Information) displaying one peak at δ 162.39
corresponding to the chemical shift of carbonyl carbon and 35
peaks in diﬀerent intensities (33 peaks each with 2C and two
peaks each with 1C) in the region of δ 125−155 that can be
accounted for all 68 fullerenyl sp2 carbons. The data are
consistent with a C70 monoadduct structure having a Cs
symmetrical ellipsoidal structure with a plane of symmetry
across the cyclopropane-bridged [6,6] bond. In general, Bingel
monoaddition reaction14 of malonate esters on C70 may lead to
four regioisomers of methano[70]fullerenes each with a
diﬀerently bridged [6,6]fullerenyl sp3 bonding location, deﬁned
as the α-type bonding at the C(1)−C(2), the β-type bonding at
the C(5)−C(6), the ε-type bonding at the C(7)−C(21), and
the κ-type bonding at the C(20)−C(21).15,16 These
regioisomers exhibit a molecular symmetry of Cs, C2v, C1, and
C2v, respectively. Chemical reactivity of all these bonding
locations was found to be the highest at the most strained
region of the cage pole area, giving the order of C(1)−C(2) >
C(5)−C(6) > C(7)−C(21) > C(20)−C(21) (lying on the ﬂat
equator of the C70 spheroid).
17 Therefore, it is reasonable for us
to predict the major monomalonate addition product
C70[>M(t-Bu)2] 4 being the α-type analogue. In fact, the
13C
spectrum of 4 showing the pattern and number of carbon
peaks, consistent with the compound having a molecular Cs
symmetry, should provide unambiguous support for this
structural assignment.
Subsequent facile transesteriﬁcation reaction of 4 with the
well-characterized tertiary amine precursor arm moiety 4-
hydroxy-[N ,N ′ ,N ,N ,N ,N-hexapropylhexa(aminoethyl)-
butanamide 5 (C3N6C3OH) was carried out under acidic
conditions using triﬂuoroacetic acid as the catalytic reagent
(Scheme 1). The reaction was found to result in the formation
of decacationic bis(20-oxo-4,7,10,13,16-pentapropyl-
4,7,10,13,16,19-hexaazatricosan-23-yl)[60]fullerenyl malonate,
protonated quaternary ammonium triﬂuoroacetate salt,
C70[>M(C3N6
+C3H)2] 7 in 71% yield. The structure of 7 was
veriﬁed by various spectroscopic techniques (Supporting
Information) including 13C NMR spectrum showing two
peaks at δ 170.45 and 165.50 corresponding to the chemical
shift of a carbonyl carbon of the amide (−HN−CO) and the
ester (−O−CO) moieties, respectively. It also displayed a
total of 68 peaks in the region of δ 125−155, accounting for 68
fullerenyl sp2 carbons. The spectral data clearly indicated a C1
symmetry for compound 7. As the simple transesteriﬁcation
condition should not complicate the structural conﬁguration of
methano[70]fullerene cage moiety, the decrease of molecular
symmetry from Cs of 4 may be indicative of strong interactions
between ﬂexible hexapropylhexa(aminoethyl)butanamide arms
and the C70 cage. These interactions may induce a nonsym-
metrical environment among cage carbons. It also revealed the
likelihood of two pentacationic C3N6C3−O− arms to be
located at the vicinity of the cage surface, as shown in the
cluster form of Figure 1, presumably by the interactive binding
of multiple hydrophobic n-propyl groups.
Interestingly, we found that the use of C70-compatible
deuterated solvents, such as CDCl3 and CS2, for enhancing the
detectability of [70]fullerenyl carbon peak signals has led to the
full suppression of pentacationic arm moieties in the spectrum.
In contrast, the application of water-compatible deuterated
solvents, such as D2O and DMF-d7, signiﬁcantly reduced the
signal intensity of [70]fullerenyl carbon peaks, likely owing to
the cage aggregation.
Conversion of compound 7 to decacationic bis(20-oxo-
4,7,10,13,16-pentapropyl-4,7,10,13,16,19-hexaazatricosan-23-
yl)[70]fullerenyl malonate methyl quaternary ammonium salt,
C70[>M(C3N6
+C3)2] 2, was accompanied by multiple iodide
anions. The infrared spectrum of 2 clearly showed four sharp
characteristic bands at 794.33, 723.08, 578.72, and 530.19 cm−1
corresponding to the absorption of a C70 half-cage, revealing no
bismalonate adduct formation (with an additional malonate
addend attached at the α-bond of the opposite pole).
Unexpectedly, we were not able to detect any fullerenyl sp2
carbon signals in the 13C NMR spectrum of 2 under various
Figure 1. Proposed schematic molecular packing of C70[>M-
(C3N6
+C3)2] 2 and 2′ by taking the high water solubility of the
compound, packing tendency of C70 cages, and the analysis of their
13C NMR spectra giving the C1 symmetry for the cage moiety into
consideration. The drawing was made by using the Chem 3D program
for the energy minimization.
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deuterated solvent mixtures. However, these carbon signals
reappeared when all iodide anions were replaced by
triﬂuoroacetate anions, leading to the corresponding salt 2′.
Accordingly, the 13C NMR spectrum of 2′ displayed a peak at δ
170.45 corresponding to the chemical shift of an amide
carbonyl carbon (−HN−CO), similar to that of 7. It also
displayed a total of 68 peaks in the region of δ 125−155,
accounting for 68 fullerenyl sp2 carbons, indicating a similar C1
symmetry as that of the compound 7. The observation led to
our assumption of the possibility of reversible partial electron-
transfer from the iodide (I−) donors to C70 cages, forming a low
degree of radicalized cage moieties that signiﬁcantly reduced
the resolution of 13C signals.
The mass spectroscopic data collection of C70[>M-
(C3N6
+C3)2] was proven to be diﬃcult because of its
polycationic nature and facile fragmentations occurring at the
conjunction of the C70 cage and the decacationic malonate arm,
giving mainly the highly detectable C70 ion mass at m/z 841, as
displayed in MALDI-TOF mass spectra (Supporting Informa-
tion). Fortunately, we are able to acquire several spectra in the
high mass region showing the molecular ion mass (M+) at m/z
3340 in low intensity accompanied by several identiﬁable
fragmentation ion mass peaks at m/z 1355, 1584, 1654, 1682,
1753, 2043, and 2079. By variation of applied laser intensity,
spectra containing many ion mass peaks in signiﬁcant signal
intensity in the medium mass region can be obtained. Structural
elucidation of these ion fragments (Supporting Information) in
these two spectra allowed us to conclude (1) a clear
monoadduct structure of 2 by the sole detection of an ion
fragment mass of C70(−CH3)+ at m/z 855 without the
corresponding ion fragment mass of the bisadduct C70(−CH3)-
(>CH2)
+ at m/z 869, (2) a facile process of nearly full
dequaternization of 2 under MALDI-MS conditions giving
mostly detectable monocationic mass fragments, and (3) the
bond cleavage of n-propyl group on the nitrogen atom is faster
than that of the methyl group and the main chain moiety.
These data strongly support the molecular mass of 2 as a
(C3N6
+C3)2-malonate-C70 structure with many consistent
(C3N6Cn)2-malonate-C70 (Cn: methyl or n-propyl group)
fragments.
The molecular aggregation characteristics of amphiphilic
nanostructures 1 and 2 in water were investigated under the
preparation condition in close resemblance to that used in the
in vitro PDT studies. Typically, the sample was dissolved in
DMA under ultrasonication for a period of ∼5.0 min, giving a
master solution at 2.0 mM. A portion of this solution was then
diluted by H2O to predetermined concentrations of 1.0, 10, and
100 μM for transmission electron microscopy (TEM) measure-
ments. As a result, TEM micrographs of C60[>M(C3N6
+C3)2]
displayed no obvious bilayered fullerosome18−20 formation at
either 1.0 or 10 μM. A sporadic formation of fullerosome
vesicles each in a larger particle diameter of 60−100 nm was
observed at a higher concentration of 100 μM. In the case of
C70[>M(C3N6
+C3)2], a similar observation of no clearly
detectable bilayered fullerosome nanovesicles was found at all
concentrations of 1.0, 10, and 100 μM. There was only a small
quantity of irregularly shaped nanospherical particles of 2 found
at 10 and 100 μM. This implied that the hydrophilic strength of
two pentacationic arms overwhelm the hydrophobic character
of C60 and C70 cages, leading to high water solubility of 1 and 2
with much suppression of their tendency to form sizable
particles under PDT experimental conditions. In the light of a
slightly higher ability of the C70 moiety, with 10 more carbon
atoms in one cage, to give molecular cluster formation
compared with C60, we proposed a likely molecular cluster
packing conﬁguration of 2 and 2′ in water, as shown in Figure 1.
It includes unsymmetrical hydrophobic malonate ester arm
moiety interactions with the C70 cage that induce the loss of
molecular cage symmetry observed in its 13C NMR spectrum.
Partial blocking of the cage surface by the arms allows only a
very limit number of hydrophobic cages to undergo irregular
coalescence into a nanosphere in H2O.
The light-induced PDT eﬃciency can be correlated partially
to optical absorption extinction coeﬃcients of the PS in the
wavelength range applied. Accordingly, we studied UV−vis
spectra of C60[>M(C3N6
+C3)2] and C70[>M(C3N6
+C3)2] in
DMA at 1.0 × 10−5 M, as shown in Figure 2A, in comparison
with the parent monoadducts C60[>M(t-Bu)2] 3 and
C70[>M(t-Bu)2] 4 in CHCl3. Interestingly, the optical
absorption proﬁle of 4 showing peaks with the maxima (λmax)
located at 355, 370, 403, 462, and 539 (shoulder band) nm
matches well with those reported for the α-type C70
monoadducts,21,22 which provided further conﬁrmation of our
structural assignment of 4. Upon the structural conversion of 4
with decacationic di(C3N6C3-O)-malonate arm, the intensity of
absorption of C70[>M(C3N6
+C3)2] increases at wavelengths of
<450 nm with the disapperance of all characteristic peaks of the
monoadduct 4 into a featureless curve. Since the cage moiety
was not modiﬁed from 4, the diﬀerence may imply the
occurrence of cage cluster formation, consistent with that
proposed in Figure 1. The change leads to a higher total visible
absorption of 2 compared with the C60 analogue 1 in a ratio of
1.99 (ε2/ε1) over 400−700 nm (Figure 2A). However, an
opposite relationship was found in the UVA region (320−400
nm), giving a ε2/ε1 ratio of 0.79, indicating a stronger optical
absorption of C60 monoadduct cage in this wavelength range. It
is also interesting to note the higher ε for the protonated
quaternary ammonium triﬂuoroacetate salt, C70[>M-
(C3N6
+C3H)2] 7, compared with that for 2 over all wavelengths
(300−800 nm). To correlate the light absorption eﬃciency of 2
under PDT experimental conditions, we compared its visible
spectrum proﬁle taken in DMAc−H2O (1:19) to that in DMA
(curves a and b of Figure 2B) and found a nearly identical ε
over the range 400−700 nm. Photostability of C60[>M-
(C3N6
+C3)2] and C70[>M(C3N6
+C3)2] in aqueous solution
Figure 2. UV−vis spectra of (A) C60[>M(t-Bu)2] 3 in CHCl3,
C60[>M(C3N6
+C3)2] 1 in DMAc, C70[>M(t-Bu)2] 4 in CHCl3,
C70[>M(C3N6
+C3)2] 2 in DMAc, and C70[>M(C3N6
+C3H)2] 7 in
DMAc and (B) C70[>M(C3N6
+C3)2] 2 in (a) DMAc, (b) DMAc−
H2O (1:19), and (c) DMAc−CHCl3−CS2 (1:1:2). The concentration
of all samples is 1.0 × 10−5 M.
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was evaluated under constant irradiation using a LED light
source equipped with a ﬁber optical lens (200 mW/cm2 at 400
± 5 nm) over a period of 5.0 h. Consequently, high retention of
a UV−vis absorption proﬁle of fullerene derivatives was
observed.
ROS Probe Experiments. Illumination of C60 or C70
monoadduct derivatives with visible or UVA light promotes
its transition to a long-lived trriplet excited state via intersystem
crosing processes and subsequent intermolecular energy
transfer to the molecular oxygen, yielding a highly reactive
singlet oxygen (1O2) in type II reactions.
23 In the presence of
physiological concentration of reductants such as NADH, more
reactive ROS species, such as superoxide anion (O2
−•) and
hydroxyl radical (HO•), may be produced in polar solvent and
water.24 In this study, a comparative singlet oxygen production
eﬃciency study of compounds 1 and 2 in DMSO−H2O (1:520,
1.0 × 10−6 M) was carried out with many incremental
exposures of the sample to a Uvitron visible-enhanced lamp
(200 W, 250−600 nm with λmax at 420 nm) in an exposure
interval period of 5.0 s (the light dose measured to be ∼5.0 mJ/
cm2 per period) followed by the ﬂuorescence emission
measurement of the probe. For highly eﬃcient in situ selective
trapping of singlet oxygen, we applied water-compatible 9,10-
anthracenediyl-bis(methylene)dimalonic acid (ABMA, 8.0 ×
10−6 M) as a ﬂuorescent probe which exhibits the emission
maximum at 429 nm. The corresponding most eﬀective
excitation wavelengths were found to be 379 and 400 nm.
Accordingly, the later one closer to the visible range was used.
At this wavelength, the optical absorption extinction coeﬃcient
of 2 is slightly higher than that of 1, as shown by the blue mark
in Figure 2A. The chemical trapping of 1O2 by highly
ﬂuorescent ABMA leads to the formation of nonﬂuorescent
9,10-endoperoxide product. The conversion allows us to follow
the loss of ﬂuorescence emission intensity at 429 nm for its
correlation to the proportional quantity of 1O2 produced
because of the high kinetic rate constant of the trapping
reaction in aqueous medium,25 assuming the internal decay of
1O2 in the solvent system is identical for both experiments of 1
and 2. As a result, we observed a slightly higher 1O2 production
rate of C60[>M(C3N6
+C3)2], even though the diﬀerence is not
statistically signiﬁcant, as shown in Figure 3a. The use of a
lower irradiation dose for a similar measurement directly in the
UV−vis−NIR spectrometer, operating at λex = 400 nm (single
wavelength excitation) with the monochromator, gave a much
slower production rate of 1O2 for both cases that displayed a
clearly higher rate for C60[>M(C3N6
+C3)2] at this excitation
wavelength (Figure 3b).
A similar trend was also conﬁrmed by using 1O2 probe singlet
oxygen sensor green (SOG) reagent. Upon the trapping of 1O2
by the anthracene moiety of SOG, the resulting 9,10-
endoperoxide-linked ﬂuorescein product SOG-EP is highly
green ﬂuorescent (excitation/emission maxima of ∼504/525
nm) that can be used for the correlation of the relative 1O2
quantity produced. It is worthwhile to mention that the SOG
probe chemistry is potentially more complicated than the
statement above because of the fact that both SOG and SOG-
EP are capable of sensitizing 1O2 production and undergoing
photobleaching processes themselves, resembling those of
ﬂuorescein derivatives.26 This complication can be lessened
by using blue light for fullerene excitation that is not absorbed
by the probe. However, if we assume that the amount of the
additional 1O2 molecules derived from SOG and SOG-EP and
the photobleaching rate are nearly identical among experiments
under the same conditions, the ﬂuorescence emission intensity
of SOG-EP detected will still be valuable for a relative
comparison. Accordingly, Figure 4a shows the results from the
SOG-based ﬂuorescence probe assay experiments of 1 and 2 in
96-well black-sided plates under incremental irradiation with a
blue LED light source (415 ± 15 nm) under the total ﬂuence
intensity range of 0−6.0 J/cm2. It is evident that C60[>M-
(C3N6
+C3)2] gave a signiﬁcantly higher rate of
1O2 detected
than C70[>M(C3N6
+C3)2]. The marked diﬀerence in the
1O2
generation rate of 1 and 2 between the data of Figure 3
(without PBS) and Figure 4a (with PBS) led to our
consideration of the potential involvement of type I photo-
reaction processes in electrolyte solution giving reactive radical
species in the latter experimental conditions.
Indeed, under similar experimental procedures relevant to
PDT as those used for the data collection of Figure 4a but with
the application of the ﬂuorescent probe of 3 ′-p-
(hydroxyphenyl)ﬂuorescein27 (HPF), a reverse relationship
was observed with higher ﬂuorescence emission intensity of
ﬂuorescein for C70[>M(C3N6
+C3)2] than for C60[>M-
(C3N6
+C3)2] under the total ﬂuence intensity range of 0−5.0
J/cm2, as shown in Figure 4b. Since the HPF probe is an
essential tool for the selective detection of HO• and
peroxynitrite, via quinone formation detached from the
ﬂuorescein moiety (excitation/emission maxima of ∼490/515
nm), with the detection sensitivity reported to be roughly 145-
and 90-fold higher for HO• than for 1O2 and O2
−•,
respectively,27 the measured ﬂuorescence intensity can be
correlated roughly to the yield of hydroxyl radicals produced.
Besides, O2
−• is the precusor species to the formation of HO•.
Directly monitoring the presence of HO• will also serve to
conﬁrm superoxide radical formation, i.e., higher yield for
C70[>M(C3N6
+C3)2] than for C60[>M(C3N6
+C3)2].
It is well-recognized that 1O2 can give rise to several other
types of ROS, including O2
−•, H2O2, and HO
•, in a sequential
reaction with iodide anion (I−),28 In this case, the yield of O2
−•
or HO• should be proportional to the quantity of 1O2.
Therefore, our observation of a higher 1O2 production yield of
Figure 3. Comparison of singlet oxygen production eﬃciency of
compounds 1 and 2 in DMSO−H2O (1:520, 1.0 × 10−6 M), using
anthracene tetracarboxylic acid ABMA (8.0 × 10−6 M) as the
ﬂuorescent 1O2-trapping agent at λex 400 nm and λem 429 nm for
detection with an irradiation source of (a) Uvitron lamp (200 W) and
(b) spectrometer lamp/monchromator operated with a single
wavelength at λex 400 nm.
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C60[>M(C3N6
+C3)2] in PBS solution (Figure 4a) giving a lower
production yield of radical species (Figure 4b) revealed no
direct correlation of 1O2 to O2
−• or HO• yields, or the latter
species may not be derived directly from the former one in
these experiments. In contrast, they may be in a competitive
production process with each other in either the triplet energy-
transfer (type II) or electron-transfer (type I) mechanism
involving the electron-donating iodide anion (I−) and the
electron-accepting fullerene cage. This mechanistic path can be
realized by the facile photoexcitation of C60/C70 cages to their
singlet excited state followed by quantitative intersystem
crossing to their corresponding excited triplet transient states,
3C60*[>M(C3N6
+C3)2] and
3C70*[>M(C3N6
+C3)2]. Appa-
rently, the latter molecule exhibited a higher electron-accepting
capability to allow electron transfer from the iodide anion,
leading to the formation of C70
−•[>M(C3N6
+C3)2] prior to the
further transfer this electron to O2 that gave a higher yield of
O2
−• and thus HO•.
Antimicrobial Eﬀect of Fullerene-Mediated PDT. Two
highly water-soluble decacationic fullerenes 1 and 2 were ﬁrst
applied for comparison in the PDT-killing of the Gram-positive
S. aureus. In general, it is known that Gram-positive bacteria are
more sensitive and susceptible to PDT destruction than Gram-
negative bacteria. This allowed us to use a lower concentration
(up to 10 μM) of fullerene derivatives for S. aureus killing than
that (up to 100 μM) needed for eﬀective E. coli killing. Our
previous PDT experiments have indicated a fast binding
process of PS to microbial cells.29 Thus, a short incubation time
of 30 min was applied for both species. As shown in Figure 5,
neither decacationic fullerene derivative 1 nor 2 gave any
detectable toxicity to both bacteria in the dark at a
concentration up to 10 μM. A pronounced PDT eﬀect was
observed after illumination on the 1/2-incubated cells using a
broad-band white light source with total ﬂuence intensity of
100 J/cm2 with a sharp cytotoxicity trend even at a low
fullerene concentration of 1.0 μM, giving 3 log killing for
C60[>M(C3N6
+C3)2] and 2 log killing for C70[>M(C3N6
+C3)2].
As the administered dose increased to 3.0 μM, a 5 log killing
eﬀectiveness was observed for the compound 1 and a
corresponding 3 log for the compound 2. Interestingly,
C60[>M(C3N6
+C3)2] was able to eradicate the cells at
concentrations higher than 3.0 μM. In the case of C70[>M-
(C3N6
+C3)2], a 5 log eﬀective killing was achieved at 10 μM.
Two killing curves of 1 and 2 were signiﬁcantly diﬀerent from
each other (p < 0.01).
In the PDT experiments against E. coli, the need to use 8
times higher concentrations of fullerene drugs led to the
observation of some dark toxicity (1−2 log) at the higher
concentrations of 60 and 80 μM. Surprisingly, the order of
PDT eﬀectiveness of these two fullerene drugs was opposite to
that seen with S. aureus. In this case, C70[>M(C3N6
+C3)2] was
most eﬀective for E. coli killing with 3 log at 40 μM and 5 log at
60 μM and for eradicating the cells at 80 μM, as shown in
Figure 6. On the other hand, C60[>M(C3N6
+C3)2] only killed 1
log at 40 μM, 2 log at 60 μM, and 3 log at 80 μM. These two
curves were signiﬁcantly diﬀerent (p < 0.01).
Anticancer Eﬀect of Fullerene-Mediated PDT. A longer
incubation period of 24 h was applied for the experiments with
Figure 4. Activation of ﬂuorescence probes for detecting the ROS
generation by 1 and 2 (5.0 μM in each well) using diﬀerent ﬂuorescent
probes (a) SOG (5.0 μM) and (b) HPF (5.0 μM), followed by
delivery of the stated ﬂuence of blue light.
Figure 5. PDT killing of Gram-positive bacteria S. aureus. Bacteria [108
cells/mL] were incubated with stated concentration of C60[>M-
(C3N6
+C3)2] 1 or C70[>M(C3N6
+C3)2] 2 for 30 min followed by
delivery or not of 100 J/cm2 of white light: (∗∗) p < 0.01.
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cancer cells owing to their relatively slow process to uptake
fullerene derivatives. Furthermore as it appears that cancer cells
are more sensitive to the dark toxicity eﬀects of both fullerene
derivatives and DMA organic solvent, we kept the concen-
tration to a single low value of 2.0 μM. The irradiation was
made by a white light source (400−700 nm) delivered at an
intensity of 100 mW/cm2 with a variable ﬂuence dose of 0, 10,
20, 40, and 80 J/cm2 for giving a demonstration of a light-dose
dependence of cell killing. As depicted in Figure 7, C70[>M-
(C3N6
+C3)2] was apparently more eﬀective at cancer-cell killing
than C60[>M(C3N6
+C3)2], with 1 log of cells killing at 40 J/cm
2
and 2 log at 80 J/cm2. Since the MTT assay cannot reliably
measure more than 2 log of killing, the latter light-dose
eﬀectiveness is equivalent to eradication. By contrast, the
fullerene drug 1 killed less than 1 log at all ﬂuences up to 80 J/
cm2. These two curves were signiﬁcantly diﬀerent (p < 0.05−
0.001).
Discussion of PDT Results. The data showed interesting
diﬀerences between the photoactivity of decacationic fullerene
compounds that diﬀer only in the number of carbon atoms in
the fullerene cage. The decacationic arms attached to these
fullerenes served to give the molecules rapid binding to the
anionic residues displayed on the outer parts of bacterial cell
walls. The large number of ionic groups attached to the
fullerene also provided enhanced water solubility, which is a
necessary requirement for biological activity. Even though these
fullerenes displayed a rapid ability to photoinactivate bacteria,
they were also eﬃcient in mediating the PDT killing of cancer
cells, although a longer incubation time was needed. A large
molecular weight of these fullerenes (around 3300) means that
they are too large to diﬀuse through the plasma membrane of
mammalian cells, which is a rapid process, and are therefore
taken up by the slower process of adsorptive endocytosis. The
diﬀerences in eﬀectiveness we found between C60 and C70 was
interesting. For Gram-positive bacteria C60[>M(C3N6
+C3)2]
was better at photokilling than C70[>M(C3N6
+C3)2], while for
Gram-negative bacteria and for cancer cells the opposite was
the case, in that C70[>M(C3N6
+C3)2] was better at photokilling
than C60[>M(C3N6
+C3)2]. We have previously reported
30 that
type II reactive oxygen species (ROS), i.e., singlet oxygen, 1O2,
are better at killing Gram-positive bacteria than type I ROS, i.e.,
hydroxyl radicals, HO•, while the reverse is true for Gram-
negative bacteria (HO• is better at killing than 1O2). Therefore,
we decided to test the type of ROS (HO• or 1O2) produced
when 1 and 2 were illuminated in simple PBS solution. To do
this, it was necessary to employ blue light to excite the
fullerene, because if white light was used, the light alone would
activate the probe to some extent through the green absorption
peak. The results demonstrated that C60[>M(C3N6
+C3)2]
produced more 1O2 while C70[>M(C3N6
+C3)2] produced
more HO•. This ﬁnding oﬀers an explanation of the preferential
killing of Gram-positive bacteria by 1 and the preferential
killing of Gram-negative bacteria by 2. The hypothesis is that
1O2 can diﬀuse more easily into porous cell walls of Gram-
positive bacteria to reach sensitive sites, while the less
permeable Gram-negative bacterial cell wall needs the more
reactive HO• to cause real damage31,32 It has not been reported
whether HO• or 1O2 is more eﬃcient in killing cancer cells, but
our data would suggest that HO• may be more eﬀective in this
case as well.
■ CONCLUSION
A novel water-soluble decacationic armed C70 monoadduct
decaiodide C70[>M(C3N6
+C3)2] was synthesized, characterized,
and applied as a PS and potential nano-PDT agent against
pathological bacteria and cancer cells. The arm structure was
designed to include a large number of cationic charges per C70,
and H-bonding moieties were designed for rapid binding to the
anionic residues displayed on the outer parts of bacterial cell
walls and high water-solubility. The use of propyl groups on
quaternary ammonium salt moieties was to provide an
interaction balance between the arm moieties and the cage in
the presence of water. These structural characterisatics were
found to overwhelm the hydrophobicity of the fullerene cage
moiety that largely prohibited a sizable cage aggregation in
water.
Figure 6. PDT killing of Gram-negative bacteria E. coli. Bacteria [108
cells/mL] were incubated with stated concentration of 1 or 2 for 30
min followed by delivery or not of 100 J/cm2 of white light: (∗∗) p <
0.01.
Figure 7. PDT killing of human cancer cells. HeLa cells were
incubated with 2.0 μM C60[>M(C3N6
+C3)2] 1 or C70[>M(C3N6
+C3)2]
2 for 24 h, followed by delivery of stated ﬂuence of white light. The
cells were then returned to incubator for 24 h. The MTT assay was
then carried out: (∗) p < 0.05; (∗∗) p < 0.01; (∗∗∗) p < 0.001.
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In the presence of a high number of electron-donating iodide
anions as parts of quaternary ammonium salts in the arm
region, we found that C70[>M(C3N6
+C3)2] produced more
HO• than C60[>M(C3N6
+C3)2], in addition to
1O2. Both ROS
were detected using several ﬂuorescence probes. This ﬁnding
oﬀers an explanation of the preferential killing of Gram-positive
and Gram-negative bacteria by C60[>M(C3N6
+C3)2] and
C70[>M(C3N6
+C3)2], respectively. The data are consistent
with the hypothesis that 1O2 can diﬀuse more easily into porous
cell walls of Gram-positive bacteria to reach sensitive sites,
while the less permeable Gram-negative bacterial cell wall needs
the more reactive HO• to cause real damage. Since the
production rate of 1O2 was detected in a similar range for 1 and
2 in the absence of PBS, the diﬀerences shown in the presence
of PBS electrolyte salts led to our suggestion that the observed
production of HO• may arise partially from the photoinduced
electron-transfer (type I) mechanism involving the electron-
donating iodide anions (I−) and the fullerene cages at their
excited triplet transient states, 3C60*[>M(C3N6
+C3)2] and
3C70*[>M(C3N6
+C3)2], having diﬀerent electron-accepting
strength. The presence of electrolyte salts makes the ion
exchange and I− dissociation possible and increases the
eﬃciency of electron transport that forms the corresponding
C60
−•[>M(C3N6
+C3)2] and C70
−•[>M(C3N6
+C3)2], respec-
tively, as the source for the O2
−• and the derived ROS radicals
generation.
We previously reported33 that antimicrobial PDT using a
cationic functionalized fullerene and white light for mice with
wounds that were heavily contaminated with bacteria could
prevent the death of mice due to the development of sepsis.
The possible clinical application of fullerenes as PDT agents is
to some degree limited by the need to use shorter wavelength
light for excitation, but we have also recently reported34 that
this drawback can actually be an advantage when shorter
penetration into tissue is desired. The temporal selectivity
(short times give binding to bacteria, while long times allow
uptake into mammalian cells) suggests that the same agents
could be used to treat both infections and cancer.35 When
fullerene mediated PDT is used with a long incubation time, it
can kill multiple types of cancer cells, including head, neck,
breast, and esophageal cancer, that respond poorly to
alternative cancer therapies.
■ EXPERIMENTAL SECTION
Materials. Reagents γ-butyrolactone (GBL), BF3·Et2O, triethyl-
amine, 1,8-diazabicyclo[5,4,0]undec-7-ene (DBU), carbon tetrabro-
mide (CBr4), triﬂuoroacetic acid, potassium carbonate, and iodo-
methane were purchased from Aldrich Chemicals and used without
further puriﬁcation. Di-tert-butyl malonate was purchased from Tokyo
Chemical Industry Co., Ltd. A C60 sample with a purity of 99.0% and a
C70 sample with a purity of 98.0% were purchased from either Nano-
C, Inc. or Term USA, Inc. 9,10-Anthracenediyl-bis(methylene)-
dimalonic acid (ABMA) was either purchased from Santa Cruz
Biotechnology, Inc. or synthesized according to the literature
procedure.36 Sodium sulfate was employed as a drying agent. Solvents
were routinely distilled before use. Singlet oxygen sensor green (SOG)
and 3′-p-(hydroxyphenyl)ﬂuorescein (HPF) were obtained from
Invitrogen, Ltd. as solutions in either methanol (SOG) or
dimethylformamide (HPF).
Spectroscopic Measurements. Infrared spectra were recorded as
KBr pellets on a Thermo Nicolet Avatar 370 FT-IR spectrometer. 1H
NMR and 13C NMR spectra were recorded on a Bruker Avance
Spectrospin-500 spectrometer. UV−vis spectra were recorded on a
Perkin-Elmer Lambda 750 UV−vis−NIR spectrometer. MALDI mass
spectra were recorded on a WATERS Micromass MALDI-TOF mass
spectrometer. Elemental analysis was taken by Galbraith Laboratories,
Inc. These spectroscopic methods were applied for all compounds
synthesized in conjunction with elemental analysis of some
compounds to conﬁrm that the purity of samples was at least ≥95%.
Synthesis of Di(tert-butyl)[70]fullerenyl Malonate, C70[>M(t-
Bu)2] 4. Finely divided [70]fullerene (2.3 g, 2.7 mmol) was taken into
a round-bottom ﬂask. Anhydrous toluene (1.6 L) was added under
nitrogen. The solution was stirred for 12 h at ambient temperature to
ensure complete dissolution of C70. To the resulting wine-colored
solution was added carbon tetrabromide (0.56 g, 1.68 mmol) followed
by a solution of di-tert-butyl malonate (0.3 g, 1.39 mmol) in anhydrous
toluene (100 mL). The solution was stirred for an additional 30 min,
and to it was slowly added 1.8-diazabicyclo[5.4.0]-undec-7-ene (DBU,
0.52 g, 3.4 mmol) over a period of 15 min. The color of the solution
slowly turned brown in 8.0 h. The solution was then concentrated on a
rotary evaporator to roughly 50 mL. Upon the addition of methanol to
this concentrated solution, the crude product was precipitated as a
brown solid which was collected via centrifugation. Puriﬁcation of
di(tert-butyl)[70]fullerenyl malonate, C70[>M(t-Bu)2] 4, was made by
column chromatography (silica gel using toluene/hexane (1:1, v/v) as
eluent) to aﬀord a brown solid in a yield of 65.0% (0.95 g).
Spectroscopic data of the compound 4: MALDI-TOF-MS (sinapic
acid as the matrix, rel intensity) m/z 841 (C70H
+, 56%), 855
(C70CH3
+, 100%), 866 (28%), 882 (13%), 900 (79%), 913 (27%), 926
(28%), 944 (11%), 1023 (8%), 1055 (MH+, 5%), and 1056 (8%); FT-
IR (KBr) νmax 3444 (vs, water peak), 2997 (w), 2974 (m, −C−H
stretching), 2923 (m, −C−H stretching), 2849 (w), 1741 (vs, malonyl
ester −CO), 1720 (s, malonyl ester −CO), 1647 (m), 1468 (w),
1451 (m, antisymmetric deformations of −CH3), 1427 (s), 1391 (m),
1366 (s, symmetric deformations of CH3), 1308 (w), 1273 (s), 1250
(s, asymmetric stretching of −C−C(O)-O−), 1150 (vs, −C−O−t-
Bu stretching and C(C60)−C−C(O)− deformations), 1093 (s),
1025 (w), 954 (w), 877 (w), 843 (m), 794 (m, C70), 752 (m), 671 (m,
C70), 649 (w), 640 (m), 577 (s, C70), 532 (s, C70), and 458 (m, C70)
cm−1; UV−vis (CHCl3, cutoﬀ at 245 nm, 1.0 × 10−5 M) λmax 322, 355,
370, 403, 462, and 539 (shoulder band) nm; 1H NMR (500 MHz,
CDCl3, ppm) δ 1.68 (s, 18H);
13C NMR (500 MHz, CDCl3−CS2,
ppm) δ 162.39 (−CO), 155.41 (2C), 151.57 (2C), 151.32 (2C),
150.86 (2C), 150.74 (2C), 149.48 (2C), 149.39 (2C), 149.21 (2C),
148.76 (2C), 148.71 (2C), 148.68 (2C), 148.62 (2C), 147.78 (2C),
147.71 (2C), 147.46 (2C), 147.15 (2C), 146.60, 146.09 (2C), 146.05
(2C), 145.06 (2C), 145.01, 144.10 (2C), 144.00 (2C), 143.63 (2C),
143.36 (2C), 142.93 (2C), 142.24 (2C), 141.81 (2C), 140.77 (2C),
137.30 (2C), 133.74 (2C), 132.98 (2C), 131.05 (2C), 130.97 (2C),
130.95 (2C), 84.86 (2C), 28.25 (6C), indicating a molecular Cs
symmetry for 4.
A similar procedure was applied for the preparation of di(tert-
butyl)[60]fullerenyl malonate, C60[>M(t-Bu)2] 3, in a yield of 62.0%.
Spectroscopic data: MALDI-TOF-MS (sinapic acid as the matrix, rel
intensity) m/z 721 (C60H
+, 70%), 734 (C60CH2
+, 100%), 747
(C60CHCH2
+, 37%), 780 (75%), 794 (21%), 805 [C60C(CO)-
(CO2H)
+, 24%], 824 (20%), 919 (12%), 921 (11%), 935 (MH+,
5%), and 937 (7%); FT-IR (KBr) νmax 3429 (vs, water peak), 2976 (m,
−C−H stretching), 2924 (m, −C−H stretching), 2849 (m), 1741 (vs,
malonyl ester −CO), 1633 (m), 1454 (s, antisymmetric
deformations of −CH3), 1427 (m), 1392 (m), 1367 (s, symmetric
deformations of CH3), 1273 (vs), 1253 (vs, asymmetric stretching of
−C−C(O)−O−), 1155 (vs, −C−O−t-Bu stretching and C(C60)−
C-C(O)− deformations), 1113 (m), 1059 (w), 1031 (w), 846 (m),
805 (w), 733 (m), 703 (m), 578 (m), 552 (m), and 526 (vs, a
characteristic band of C60 monoadduct) cm
−1; UV−vis (CHCl3, cutoﬀ
at 245 nm, 1.0 × 10−5 M) λmax 257 and 323 (shoulder band) nm;
1H
NMR (500 MHz, CDCl3, ppm) δ 1.70 (s, 18H);
13C NMR (500 MHz,
CDCl3, ppm) δ 162.28 (−CO), 145.79, 145.36, 145.26, 145.18,
144.82, 144.72, 144.56, 143.93, 143.17, 143.15, 143.05, 143.03, 142.30,
141.96, 140.95, 139.00, 84.42, and 72.26, consistent with the structure
of 3.
Synthesis of 4-Hydroxy-[N,N′,N,N,N,N-hexapropylhexa-
(aminoethyl)butanamide, C3N6C3OH 5. To a solution of BF3·Et2O
(1.98 g, 13.7 mmol) in the anhydrous dichloromethane was added
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triethylamine (1.60 g, 15.8 mmol, predistilled), and the mixture was
stirred at 0 °C for a period of 30 min. In a separate ﬂask,
N,N′,N,N,N,N-hexapropylhexa(aminoethyl)amine, N5C3NH2 (1.87 g,
3.9 mmol), and γ-butyrolactone (0.40 g, 4.6 mmol) were dissolved in
dichloromethane (10 mL) and added to the above solution.
Temperature of the mixture was slowly increased to 25 °C and kept
at this temperature overnight. The reaction was quenched by the
addition of cold aqueous sodium carbonate (10%). The organic layer
was then washed sequentially with aqueous sodium carbonate (10%)
and water and subsequently dried over sodium sulfate. After removal
of the solvent, the crude product was puriﬁed by column
chromatography (alumina TLC) using CHCl3−CH3OH (9.5:0.5, v/
v) as the eluent to give a viscous light yellow liquid of 4-hydroxy-
[N,N′,N,N,N,N-hexapropylhexa(aminoethyl)butanamide C3N6C3OH
5 in 60.0% yield (1.32 g). Spectroscopic data of the compound 5:
FT-IR (KBr) νmax 3304 (s, −O−H), 2957 (vs, −C−H stretching),
2933 (vs, −C−H stretching), 2872 (vs), 2807 (vs), 1650 (vs, amide
carbonyl −CO), 1555 (s), 1540 (s), 1459 (s), 1381 (m), 1189 (m,
−C−C(O)−NH− and −C(CO)−NH−C− stretchings), 1077
(s, −C−O− stretching), and 749 (w) cm−1; 1H NMR (500 MHz,
CDCl3, ppm) δ 3.66 (t, 2H, methylene protons of −CH2−OH), 3.27
(t, 2H, methylene protons of −CH2−NH2), 2.68−2.32 (br, 32H,
amine N-attached −CH2− protons of ethyleneamino moiety), 1.83
(m, 2H, methylene protons of −CO−CH2−CH2−CH2−OH), 1.44
(m, 12H, CH3−CH2−CH2−N−), and 0.86 (m, 18H, CH3−CH2−
CH2−N−); 13C NMR (500 MHz, CDCl3, ppm) δ 173.62 (amide
−NH−CO), 62.14, 57.45, 57.37, 57.00, 56.94, 56.93, 56.89, 56.84,
56.82, 56.77, 52.93, 52.63, 52.48, 52.43, 52.34, 51.74, 37.70, 34.19,
28.56, 20.44, 20.36, 20.34, 20.30, 20.20, 19.89, 12.12 (4C), and 12.05
(2C).
Synthesis of Bis(20-oxo-4,7,10,13,16-pentapropyl-
4,7,10,13,16,19-hexaazatricosan-23-yl)[70]fullerenyl Malo-
nate, Protonated Quaternary Ammonium Triﬂuoroacetate
Salt, C70[>M(C3N6
+C3H)2] 7. The compound C70[>M(C3N6
+C3H)2]
7 was synthesized by a transesteriﬁcation reaction with the following
procedure. To a solution of C70[>M(t-Bu)2] 4 (0.15 g, 0.14 mmol) in
1,2-dichloroethane was added C3N6C3OH 5 (0.23 g, 0.40 mmol) and
triﬂuoroacetic acid (1.0 g, 8.8 mmol). The solution was heated under
reﬂux for a period of 3.0 days until no C70[>M(t-Bu)2] was detected
on an analytical TLC plate (SiO2 with toluene as the eluent). Upon
completion of the reaction, the mixture was washed with ice-cold
aqueous potassium carbonate and water brieﬂy, dried over sodium
sulfate, followed by solvent evaporation to give a brown solid. The
excessive C3N6C3OH was removed by several ethyl acetate washings.
The product was then quaternized by the addition of triﬂuoroacetic
acid to aﬀord bis(20-oxo-4,7,10,13,16-pentapropyl-4,7,10,13,16,19-
hexaazatricosan-23-yl)[60]fullerenyl malonate, protonated quaternary
ammonium triﬂuoroacetate salt, C70[>M(C3N6
+C3H)2] 7, in a yield of
71% (0.32 g). Spectroscopic data of the compound 7: FT-IR (KBr)
νmax 3441 (vs, water peak), 3006 (m), 2968 (s, −C−H stretching),
2929 (s, −C−H stretching), 2871 (m), 2852 (m), 1727 (m, malonyl
ester −CO), 1648 (vs, amide carbonyl −CO), 1551 (w), 1453
(vs, antisymmetric deformations of −CH3), 1433 (s), 1387 (m), 1372
(m, symmetric deformations of CH3), 1280 (w), 1252 (w), 1197 (w),
1155 (s, C(C60)−C−C(O)− deformations and −C−O−C−
stretching), 1095 (m), 1034 (m), 946 (s), 880 (w), 840 (w), 796
(s, C70), 750 (s), 708 (w), 658 (w), 625 (w), 582 (s, C70), 536 (s, C70),
and 469 (br) cm−1; UV−vis (DMF, cutoﬀ at 268 nm, 1.0 × 10−5 M)
λmax 327−563 nm (a broad shoulder band); 1H NMR (500 MHz,
CDCl3−CS2−DMF-d7, ppm) δ 4.0−4.15 (m, br, 4H, carboxylated
methylene protons −C(O)−O−CH2−), 3.32−4.0 (m, br, 56H,
protonated quaternary ammonium ethylene protons −N+−CH2−),
3.11−3.20 (m, br, 8H, including −C(O)−NH−CH2−), 2.28 (m,
4H, −CO−CH2−CH2−CH2−OH), 1.76 (m, 24H, CH3−CH2−CH2−
N−), and 0.97 (m, 36H, CH3−CH2−CH2−N−); 13C NMR (500
MHz, CDCl3−CS2−DMSO-d6, ppm) 170.45 (amide −NH−CO),
165.50 (ester −O−CO), 155.81, 155.65, 155.51, 154.24, 153.64,
150.31, 150.28, 149.83, 149.65, 149.37, 149.11, 148.85, 148.84, 147.53,
147.49, 147.41, 147.36, 147.15, 146.83, 146.74, 146.72, 146.63, 146.61,
146.55, 146.54, 146.50, 145.88, 145.80, 145.62, 145.55, 145.18, 145.15,
144.59, 144.29, 144.18, 144.10, 144.04, 143.99, 143.44, 142.51, 142.25,
142.19, 142.08, 142.00, 141.89, 141.53, 141.45, 141.21, 140.82, 140.75,
140.31, 140.19, 139.73, 139.03, 138.67, 138.60, 137.83, 137.16, 136.02,
132.08, 131.86, 130.96, 130.92, 130.27, 129.05, 128.96 (2C), and
128.88 for the fullerenyl sp2 carbons, indicating a C1 symmetry for the
fullerene cage. Signals of aliphatic carbons of the polycationic arm
moiety were low because of the high incompatibility of this moiety
under the current solvent mixture used.
A similar procedure was applied for the preparation of bis(20-oxo-
4,7,10,13,16-pentapropyl-4,7,10,13,16,19-hexaazatricosan-23-yl)[60]-
fullerenyl malonate, protonated quaternary ammonium triﬂuoroacetate
salt, C60[>M(C3N6
+C3H)2] 6, in 65.2% yield. Spectroscopic data: FT-
IR (KBr) νmax 3436 (vs), 2957 (s, −C−H stretching), 2927 (s, −C−H
stretching), 2868 (m), 2843 (m), 2809 (m), 1714 (m, malonyl ester
−CO), 1622 (vs, amide carbonyl −CO), 1523 (w), 1456 (s,
antisymmetric deformations of −CH3), 1428 (m), 1361 (m,
symmetric deformations of CH3), 1322 (w), 1184 (m), 1152 (m,
C(C60)−C−C(O)− deformations and −C−O−C− stretching),
1046 (m), 740 (s), 706 (s), 573 (m), and 526 (vs, a characteristic band
of C60 monoadduct) cm
−1; UV−vis (CHCl3, cutoﬀ at 245 nm, 1.0 ×
10−5 M) λmax 285 nm (shoulder peak);
1H NMR (500 MHz, CDCl3−
CS2−DMF-d7, ppm) δ 4.0−4.25 (m, br, 4H, carboxylated methylene
protons −C(O)−O−CH2−), 3.32−4.10 (m, br, 56H, protonated
quaternary ammonium ethylene protons −N+−CH2−), 3.11−3.20 (m,
br, 8H, including −C(O)−NH−CH2−), 2.34 (m, 4H, −CO−
CH2−CH2−CH2−OH), 1.68 (m, 24H, CH3−CH2−CH2−N−), and
0.88 (m, 36H, CH3−CH2−CH2−N−); 13C NMR (500 MHz,
CDCl3−CS2−DMF-d7, ppm) 147.99 (2C), 145.79 (2C), 144.82
(2C), 144.36 (2C), 144.18 (2C), 144.14 (2C), 144.10 (2C), 144.05,
143.74, 143.66 (2C), 143.64 (2C), 143.55 (2C), 143.46 (2C), 143.28
(2C), 142.96 (2C), 142.88, 142.73 (2C), 142.25 (2C), 142.12 (4C),
141.97 (2C), 141.93 (2C), 141.82 (2C), 141.55 (2C), 141.23 (2C),
141.13 (2C), 140.07, 139.80 (2C), 139.48 (2C), 136.74 (2C), and
135.46 (2C) for the fullerenyl sp2 carbons, indicating a C2 symmetry
for the fullerene cage. Signals of aliphatic carbons of the polycationic
arm moiety were low because of high incompatibility of this moiety
under the current solvent mixture used.
Synthesis of Decacationic Bis(20-oxo-4,7,10,13,16-pentap-
ropyl-4,7,10,13,16,19-hexaazatricosan-23-yl)[70]fullerenyl
Malonate, Methyl Quaternary Ammonium Iodide Salt, C70[>M-
(C3N6
+C3)2] 2. A suspension solution of 7 (0.20 g, 0.063 mmol) in
chloroform (20 mL) was added to potassium carbonate/DMF solution
(20 mL), and the mixture was subsequently stirred for a period of 1.0
h. To this brown solution was added iodomethane (12 mL, excess,
addition in portions over the full reaction period). The reaction
mixture was kept at 45 °C for 3.0 days. At the end of reaction,
excessive iodomethane and solvent were removed via evaporation and
the excess K2CO3 was removed by quick wash using water to give the
product C70[>M(C3N6
+C3)2] 2 in a yield of 91.0% (0.20 g).
Spectroscopic data: MALDI−TOF−MS (sinapic acid as the matrix,
rel intensity) m/z 819 (40%), 841 (C70H
+, 100%), 855 (C70−CH3+,
15%), 1355, 1584, 1654, 1682, 1753, 2043, 2079, and 3340 (M − I−);
m/z 841 (C70H
+, 80%), 855 (C70−CH3+, 100%), 913 (40%), 1036
(15%), 1124 (15%), 1344 (15%), 1369 (15%), 1440 (10%), 1577
(15%), and 1794 (15%); FT-IR (KBr) νmax 3437 (vs, water peak),
3006 (m), 2957 (m, −C−H stretching), 2923 (s, −C−H stretching),
2852 (m), 1735 (m, malonyl ester −CO), 1642 (vs, amide carbonyl
−CO), 1465 (vs), 1427 (m), 1385 (m), 1317 (w), 1243 (w), 1209
(w), 1157 (w), 1111 (w), 1043 (m), 943 (m), 794 (m, C70), 757 (w),
723 (w), 671 (m, C70), 618 (m), 579 (s, C70), 530 (s, C70), 501 (m),
and 459 (m) cm−1; UV−vis (DMF, cutoﬀ at 268 nm, 1.0 × 10−5 M)
λmax 327−563 nm (a broad shoulder band); 1H NMR (500 MHz,
DMSO-d6, ppm) δ 3.82−4.43 (m, br, 36H, carboxylated methylene
protons −C(O)−O−CH2− and methylated quaternary ammonium
ethylene protons −N+−CH2−), 3.10−3.69 (m, br, 32H, methylated
quaternary ammonium ethylene protons −N+−CH2− and −C(
O)−NH−CH2−), 2.22 (m, 4H, −CO−CH2−CH2−CH2−OH),
1.58−1.90 (m, 24H, CH3−CH2−CH2−N−), and 0.97 (m, 36H,
CH3−CH2−CH2−N−). Elemental analysis of 2 gave C, 43.90; H,
4.38; N, 5.09; I, 37.35%.C, 54.08; H, 4.53; N, 4.24; I, 29.14%,
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indicating a measured I/Nq (quaternary amine) ratio of 0.97 as the
same degree of quaternization on average.
A similar procedure was applied for the preparation of decacationic
bis(20-oxo-4,7,10,13,16-pentapropyl-4,7,10,13,16,19-hexaaza-tricosan-
23-yl)[60]fullerenyl malonate, methyl quaternary ammonium iodide
salt, C60[>M(C3N6
+C3)2] 1, in 92.0% yield. Spectroscopic data:
MALDI−TOF−MS (sinapic acid as the matrix, rel intensity) m/z 703
(50%), 721 (C60H
+, 100%), 759 (20%), 928 (40%), 946 (20%), 1595,
1648, 1682, 1839, 1989, 2039, 2152 (10%), 2359 (10%), 2468, 2626,
2794, 2838, 2852, and 3220 (M − I−); ESI−MS (rel intensity) m/z
630, 720 (C60), 871 [C60−C(CO−O−CHCH)2+, 100%], 872, 885,
942, 949, 984, 985, 1043 (30%), 1045, 1067, 1114, 1208, 1210, 1282,
1570 [a group of six peaks, 8%, M+ − 10I − 8(CH2CH2CH3) −
4HCH3 − HN(CH2CH2CH3)2, consistent with further fragmentations
from the peak of m/z 1760], 1587, 1591, 1608, 1623, 1625, 1741, 1742
(3%), and 1760 [a group of seven peaks, 2%, MH+ − 10I −
6(CH2CH2CH3) − 4CH3, consistent with a mass of fully decationized
1, giving evidence of a C60 malonate monoadduct with two 4-
hydroxyhexa(aminoethyl)butanamide main chains]; FT-IR (KBr) νmax
3427 (vs, water peak), 2964 (s, −C−H stretching), 2928 (s, −C−H
stretching), 2874 (m), 2850 (m), 1752 (w, malonyl ester −CO),
1711 (w), 1650 (vs, amide carbonyl −CO), 1457 (vs), 1373 (m),
1320 (w), 1182 (m), 1102 (w), 1080 (m), 1032 (s), 947 (m), 756 (w),
727 (m), 708 (w), 693 (w), 578 (m), and 526 (vs, a characteristic
band of C60 monoadduct) cm
−1; UV−vis (DMF, cutoﬀ at 268 nm, 1.0
× 10−5 M) λmax 323 nm (shoulder peak);
1H NMR (500 MHz,
DMSO-d6, ppm) δ 3.82−4.43 (m, br, 36H, carboxylated methylene
protons −C(O)−O−CH2− and methylated quaternary ammonium
ethylene protons −N+−CH2−), 3.10−3.69 (m, br, 32H, methylated
quaternary ammonium ethylene protons −N+−CH2− and −C(
O)−NH-CH2−), 2.22 (m, 4H, −CO−CH2−CH2−CH2−OH), 1.58−
1.90 (m, 24H, CH3−CH2−CH2−N−), and 0.97 (m, 36H, CH3−
CH2−CH2−N−). Elemental analysis of 1 giving C, 54.08; H, 4.53; N,
4.24; I, 29.14% indicated a measured I/Nq (quaternary amine) ratio of
0.92 as the same degree of quaternization on average.
Synthesis of Decacationic Bis(20-oxo-4,7,10,13,16-pentap-
ropyl-4,7,10,13,16,19-hexaazatricosan-23-yl)[70]fullerenyl
Malonate, Methyl Quaternary Ammonium Triﬂouroacetate
Salt, C70[>M(C3N6
+C3)2] 2′. Ion-exchange reaction of the compound
C70[>M(C3N6
+C3)2] 2 (30 mg, 0.0087 mmol) was carried out in DMF
solution by the addition of an excess quantity of aqueous CF3COONa.
The mixture was heated at 50 °C and sonicated for a period of 1.0 h.
The product was precipitated from the solution upon the addition of
methanol. The solids were washed by methanol and diethyl ether. The
resulting solids were subjected to a repeated ion-exchange procedure
and followed by drying under vacuum to aﬀord the corresponding
methyl quaternary ammonium salt C70[>M(C3N6
+C3)2] 2′ with
triﬂouroacetate anions in a nearly quantitative yield. Spectroscopic
data: FT-IR (KBr) νmax 3436 (vs, water peak), 3006 (m), 2969 (s,
−C−H stretching), 2932 (m, −C−H stretching), 2877 (m), 2757
(m), 1726 (m, malonyl ester −CO), 1640 (s, amide carbonyl −C
O), 1457 (s), 1431 (m), 1332 (w), 1209 (m), 1156 (s), 1086 (m),
1018 (m), 945 (s), 880 (m), 794 (m, C70), 754 (w), 673 (m, C70), 576
(s, C70), 532 (s, C70), and 472 (m) cm
−1; 1H NMR (500 MHz,
CDCl3−CS2−DMSO-d6, ppm) δ 4.09−4.39 (m, br, 36H, carboxylated
methylene protons −C(O)−O−CH2− and methylated quaternary
ammonium ethylene protons −N+−CH2−), 2.86−3.50 (m, br, 32H,
methylated quaternary ammonium ethylene protons −N+−CH2− and
−C(O)−NH−CH2−), 2.12 (m, 4H, −CO−CH2−CH2−CH2−
OH), 1.45−1.95 (m, 24H, CH3−CH2−CH2−N−), and 0.74−1.11 (m,
36H, CH3−CH2−CH2−N−); 13C NMR (500 MHz, CDCl3−CS2−
DMSO-d6, ppm) 170.45 (amide −NH−CO), 155.81, 155.67,
155.50, 154.20, 153.10, 150.31, 149.83, 149.65, 149.37, 149.11, 148.87,
148.84, 148.82, 147.84, 147.64, 147.53, 147.49, 147.41, 147.36, 147.15,
146.83, 146.74, 146.72, 146.63, 146.61, 146.23, 146.21, 146.15, 146.10,
145.88, 145.80, 145.62, 145.55, 145.18, 145.15, 144.59, 144.38, 144.36,
144.34, 144.29, 144.10, 144.04, 143.99, 143.45, 142.51, 142.26, 142.22,
142.21, 142.19, 141.53, 141.45, 141.21, 141.15, 140.82, 140.31, 140.19,
139.73, 137.79, 137.77, 134.97, 134.15, 131.86, 130.96, 130.92, 129.05,
129.00, 128.94, and 128.88 for the fullerenyl sp2 carbons, indicating a
C1 symmetry for the fullerene cage. Signals of aliphatic carbons of the
polycationic arm moiety were low because of high incompatibility of
this moiety under the current solvent mixture used.
A similar procedure was applied for the preparation of decacationic
bis(20-oxo-4,7,10,13,16-pentapropyl-4,7,10,13,16,19-hexaazatricosan-
23-yl)[60]fullerenyl malonate, methyl quaternary ammonium triﬂour-
oacetate salt, C60[>M(C3N6
+C3)2] 1′. Spectroscopic data: FT-IR
(KBr) νmax 3448 (vs, water peak), 2970 (s, −C−H stretching), 2924
(s, −C−H stretching), 2877 (m), 2846 (m), 1728 (s, malonyl ester
−CO), 1647 (vs, amide carbonyl −CO), 1457 (vs), 1393 (w),
1368 (m), 1251 (w), 1213 (m), 1186 (m), 1154 (vs), 1111 (s), 1090
(s), 1019 (m), 944 (m), 752 (m), 613 (m), 576 (m), and 526 (vs, a
characteristic band of C60 monoadduct) cm
−1; 1H NMR (500 MHz,
CDCl3−CS2−DMSO-d6, ppm) δ 4.09−4.39 (m, br, 36H, carboxylated
methylene protons −C(O)−O−CH2− and methylated quaternary
ammonium ethylene protons −N+−CH2−), 2.86−3.50 (m, br, 32H,
methylated quaternary ammonium ethylene protons −N+−CH2− and
−C(O)−NH−CH2−), 2.12 (m, 4H, −CO−CH2−CH2-CH2−OH),
1.45−1.95 (m, 24H, CH3−CH2−CH2−N−), and 0.74−1.11 (m, 36H,
CH3−CH2−CH2−N−); 13C NMR (500 MHz, CDCl3−CS2−DMSO-
d6, ppm) 147.09 (2C), 144.37 (2C), 143.85, 143.81 (2C), 143.69
(2C), 143.67, 143.61 (2C), 143.28 (2C), 143.23 (2C), 143.14 (2C),
143.03 (2C), 142.65, 142.35 (2C), 142.22 (2C), 141.89, 141.60 (4C),
141.48 (2C), 141.45 (2C), 140.70 (2C), 139.52 (2C), 139.38 (2C),
139.16 (2C), 138.77 (2C), 138.53 (2C), 138.23 (2C), 137.76 (2C),
137.33 (2C), 136.68 (2C), 136.67 (2C), and 136.58 (2C) for the
fullerenyl sp2 carbons, indicating a C2 symmetry for the fullerene cage.
Signals of aliphatic carbons of the polycationic arm moiety were low
because of high incompatibility of this moiety under the current
solvent mixture used.
Cell Culture. A human cervical cancer cell line HeLa37 was
obtained from ATCC (Manassas, VA). The cells were cultured in
RPMI medium with L-glutamine and NaHCO3 supplemented with
10% heat-inactivated fetal bovine serum, penicillin (100 U/mL)
(Sigma, St. Louis, MO) at 37 °C in 5% CO2 humidiﬁed atmosphere in
75 cm2 ﬂasks (Falcon, Invitrogen, Carlsbad, CA). When the cells
reached 80% conﬂuence, they were washed with phosphate buﬀered
saline (PBS) and harvested with 2.0 mL of 0.25% trypsin−EDTA
solution (Sigma). Cells were then centrifuged and counted in trypan
blue to ensure viability and plated at a density of 5000/well in ﬂat-
bottom 96-well plates (Fisher Scientiﬁc, Pittsburgh, PA).
Bacterial Culture. Staphylococcus aureus 8325-4 and Escherichia coli
K12 (both wild type) were obtained from ATCC. Planktonic bacterial
cells were cultured in brain−heart infusion (BHI) broth with aeration
at 37 °C to stationary phase overnight and refreshed to mid-log
growth phase for 2.0 h the next day. Cell numbers were estimated by
measuring the optical density (OD) at 600 nm [OD of 0.5 = 108 cells/
mL].
Light Source for Bioexperiments. We used a white (400−700
nm) broad-band light source (Lumacare, Newport Beach, CA) set to
deliver a spot of 5.0 cm diameter at an irradiance of 100 mW/cm2. The
power was measured with a power meter (model DMM 199 with 201
standard head, Coherent, Santa Clara, CA).
PDT of Bacteria. Mid-log phase cells were collected through
centrifugation (1000g) for 5 min and then suspended in PBS. A cell
suspension consisting of 108 cells/mL for bacteria was incubated with
fullerene for 30 min at room temperature in the dark. Then 500 μL
aliquots of cell suspension were transferred to a 48-well plate and
fullerene derivative, 1 or 2, was added (up to 10 μM for S. aureus and
up to 80 μM for E. coli) from a DMA stock solution prepared at 2.0
mM. The highest concentration (for 80 μM fullerene) of DMA used
was 4%, and this did not cause any toxicity to the cells. Cells were
illuminated at room temperature for 16.6 min to deliver 100 J/cm2. At
the completion of the illumination period, 100 μL aliquots were
removed from illuminated and nonilluminated wells (cells incubated
with fullerene but kept in 48-well plates covered with aluminum foil at
room temperature for the duration of the illumination were used as
control) and serially diluted 10-fold in PBS to give dilutions of 10−1−
10−6 times the original concentrations, and 10 μL aliquots of each of
the dilutions were streaked horizontally on square BHI plates by the
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method of Jett and colleagues.38 Plates were streaked in triplicate and
incubated for 24 h at 37 °C in the dark to allow colony formation.
Controls groups included cells that were not treated with fullerene or
light and cells treated with light but not with fullerene. Survival
fractions (SF) were routinely expressed as ratios of CFU of microbial
cells treated with light and fullerene or treated with fullerene in the
dark to CFU of microbes treated with neither.
PDT of Cancer Cells. After cells had grown for 24 h, dilutions of
fullerene derivatives were prepared in complete RPMI medium
containing 10% serum, penicillin (100 U/mL), and streptomycin
(100 μg/mL) and added to the cells at 2.0 μM for an additional
incubation of 24 h. The highest DMA concentration in the medium
did not exceed 0.1%. The medium was replaced with fresh complete
medium, and white light (400−700 nm with a ﬂuence of 0, 10, 20, 40,
and 80 J/cm2) was delivered at an irradiance of 100 mW/cm2. The
light spot covered four wells, which were considered as one
experimental group illuminated at the same time. Control groups
were as follows: no treatment, light alone, and fullerene alone (at the
same dilution used for PDT experiments). Following PDT treatment
the cells were returned to the incubator overnight and a 4.0 h MTT
assay was carried out the next day and read at 562 nm using a
microplate spectrophotometer (Spectra Max 340 PC, Molecular
Devices, Sunnyvale, CA). Each experiment was repeated 3 times.
Fluorescence Probe Assay Procedures. The 96-well black-sided
plates were used for ﬂuorescence probe experiments. SOG (in
methanol) or HPF (in DMF as provided by Invitrogen, Ltd. with a
ﬁnal concentration of 5.0 μM) was added to 5.0 μM C60[>M-
(C3N6
+C3)2] 1 or C70[>M(C3N6
+C3)2] 2 in phosphate buﬀered saline
(PBS) solution (200 μL) per well. Fluorescence spectrometry
(SpectraMax M5 plate reader, Molecular Devices, Sunnyvale, CA)
used excitation and emission at 504 and 525 nm for SOG and 490 and
515 nm for HPF, respectively. Increasing ﬂuence (J/cm2) was
delivered using a blue LED light source (415 ± 15 nm, Clear-U,
Photomedex, Montgomeryville, PA) at an irradiance of 20 mW/cm2.
Each time after an incremental ﬂuence was delivered, the ﬂuorescence
was measured.
Statistics. Values are the mean of three separate experiments, and
bars presented in the graphs are standard errors of the mean (SEM).
Diﬀerences between mean values were statistically analyzed by one-
way ANOVA in Microsoft Excel, and p < 0.05 was considered
signiﬁcant.
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